Immatics (IMTX) Shares Outstanding (Weighted Average) (2019 - 2025)

Immatics' (IMTX) quarterly Shares Outstanding (Weighted Average) came in at $1.5 billion in Q4 2025, up 993879351.98% year-on-year from N/an in Q4 2024, and up 104593833.35% quarter-over-quarter from $1421.6 in Q3 2025.

Immatics (IMTX) Shares Outstanding (Weighted Average) (2019 - 2025) Analysis & Trends

Immatics has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $1.5 billion for Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $1.5 billion, up 993879351.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 billion (up 993879351.98% YoY), and the FY2025 annual result was $1.4 billion, up 964651231.38% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $1.5 billion for Q4 2025 at Immatics, up from $1421.6 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.5 billion in Q4 2025 to a low of $10.86 in Q1 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $70.3 million (2021), against an average of $269.6 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) plunged 100.0% in 2024 and surged 11294464339.2% in 2025, its largest moves.
  • Immatics' Shares Outstanding (Weighted Average) stood at $72.0 million in 2021, then decreased by 4.71% to $68.6 million in 2022, then rose by 26.36% to $86.7 million in 2023, then slumped by 100.0% to $149.6 in 2024, then surged by 993879351.98% to $1.5 billion in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $1.5 billion (Q4 2025), $1421.6 (Q3 2025), and $1.3 billion (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Immatics 14.67 Bn 14.67 Bn - 1.49 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.49 Bn
Sep 30, 2025 1,421.57
Jun 30, 2025 1.33 Bn
Mar 31, 2025 1.23 Bn
Dec 31, 2024 149.60
Sep 30, 2024 43.93
Jun 30, 2024 111.00 Mn
Mar 31, 2024 10.86
Dec 31, 2023 86.66 Mn
Sep 30, 2023 90.77 Mn
Jun 30, 2023 631,576.15
Mar 31, 2023 773.11 Mn
Dec 31, 2022 68.58 Mn
Sep 30, 2022 796.54
Jun 30, 2022 1,195.10
Mar 31, 2022 1,526.38
Dec 31, 2021 71.97 Mn
Sep 30, 2021 74.19 Mn
Jun 30, 2021 939.33
Mar 31, 2021 75.88 Mn